Spontaneous oral bleeding in leukemia patients. Leukemia of unspecified cell type
Conditions
Interventions
Intervention group The intervention group receives five percent nanotrangasmic acid mouthwash. Each subject will receive 4 containers of 280 ml containing mouthwash. Each patient is taught to use 20 m
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Leukemia patients with oral bleeding Patients diagnosed with thrombocytopenia (platelet count less than 20,000 units) Selection of patients with the same frequency of use as assigned random classification Selection of patients with the same interval of chemotherapy
Exclusion criteria
Exclusion criteria: Use of any anti-coagulant or anti-coagulant drugs (such as ASA, NSAID, ...) in the last month Pregnant or nursing mothers Hypersensitivity to tranexamic acid Use of birth control pills Smokers Presence of severe periodontitis The presence of diseases that prohibit the use of anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of times of spontaneous oral bleeding? the presence of spontaneous oral bleeding? the number of bleeding interdental areas after using an interdental toothbrush by the researcher. Timepoint: Measuring the number of bleeding interdental areas before the start of the intervention and 14 days after the start of the intervention? Measuring the number of bleeding times before and after using mouthwash (every day up to two weeks)? Identifying the presence of oral bleeding before and after using mouthwash (every day up to two weeks ). Method of measurement: Evaluation of the presence of bleeding by questionnaire - Evaluation of the number of bleeding areas by the researcher through interdental toothbrushes - Evaluation of the number of bleeding times by questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAliye sensebli
Gorgan University of Medical Sciences
Outcome results
None listed